Potential risks for the off-label use of SSRIs in premature ejaculation CME

Journal of Sexual Medicine

Volumn 7, Issue 8, 2010, Pages 2622-2624

  Lee, Jay ^a  

^a Southern Alberta Institute of Urology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; DAPOXETINE; FLUOXETINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PRILIGY; PROCAINAMIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ANAMNESIS; ANXIETY DISORDER; ARTICLE; BLEEDING; CASE REPORT; CONDOM; DEEP VEIN THROMBOSIS; DEPRESSION; DROWSINESS; DRUG APPROVAL; DRUG INDICATION; EJACULATION; HUMAN; HYPERHIDROSIS; HYPOKALEMIA; KNEE ARTHROPLASTY; LIBIDO DISORDER; MALE; NAUSEA; OFF LABEL DRUG USE; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT SATISFACTION; PENIS ERECTION; PENIS GLANS; PRACTICE GUIDELINE; PREMATURE EJACULATION; PRESCRIPTION; PRIORITY JOURNAL; QT PROLONGATION; REHABILITATION CARE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEXUAL BEHAVIOR; SEXUAL EXERCISE; SEXUAL SATISFACTION; SEXUALITY; SINUS TACHYCARDIA; SKIN BRUISING; SUICIDAL IDEATION; SUPRAVENTRICULAR TACHYCARDIA; XEROSTOMIA;

EID: 77955286240     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01945.x     Document Type: Article

References (14)

1. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: A double blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998, 18:274-81.
2. Sharlip I. Diagnosis and treatment of premature ejaculation: The physician perspective. J Sex Med 2005, 2:103-9. suppl
3. Goodman RE. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 1980, 8(3):53-9. suppl
4. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID. AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004, 172:290-4.
5. Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-blind, placebo controlled study. J Urol 1998, 159:425-7.
6. Salonia A, Maga T, Columbo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigati P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002, 168:2486-9.
7. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001, 13:41-5.
8. Haensel SM, Klem T, Hop WJC, Slob AK. Fluoxetine and premature ejaculation. J Clin Psychopharmacol 1998, 18:1-6.
9. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB. Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial. Biol Psychiatry 1998, 44:77-87.
10. Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007, 18. CD004851
11. Wallerstedt SM, Gleerup H, Sundstrom A, Stigendal L, Ny L. Risk of clinically relevant bleeding in warfarin-treated patients-Influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009, 18:412-6.
12. Mort JR, Aparasu RR, Baer RK. Interaction between selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory durgs: Review of the literature. Pharmacotherapy 2006, 26:1307-13.
13. Jackson WK, Roose SP, Glassman AH. Cardiovascular toxicity and tricyclic antidepressants. Biomed Pharmacother 1987, 41:377-82.
14. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.